Compare
Natural Alternatives International Inc vs Cronos Group Inc. vs Mannatech Inc vs Marimed Inc.
| Latest fiscal year | Natural Alternatives International Inc NAII | Cronos Group Inc. CRON | Mannatech Inc MTEX | Marimed Inc. MRMD |
|---|---|---|---|---|
| Year ended | 2025-06-30 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $129.86M | $146.59M | $108.04M | $159.83M |
| Revenue growth (YoY) | +14.1% | +24.6% | -8.3% | +1.3% |
| Gross margin | 7.2% | 42.8% | 74.9% | 36.2% |
| Operating margin | -6.7% | -11.9% | -0.4% | -1.8% |
| Net margin | -10.5% | -6.4% | -14.1% | -9.1% |
| Net income | -$13.57M | -$9.45M | -$15.21M | -$14.48M |
| EPS (Diluted) | -$2.28 | -$0.02 | -$8.00 | -$0.04 |
| Operating cash flow | $5.93M | $25.87M | -$2.96M | $7.70M |
| Free cash flow | $2.32M | $149.0K | -$4.32M | $6.53M |
| Cash & equivalents | $12.32M | $791.79M | $6.18M | n/a |
| Total assets | $151.94M | $1.20B | $29.99M | $202.56M |
| Total liabilities | $83.51M | $54.18M | $35.22M | $137.83M |
| Shareholders' equity | $68.43M | $1.14B | -$5.22M | $50.01M |
| Return on year-end equity | -19.8% | -0.8% | n/a | -29.0% |
| Shares outstanding | 6.18M | 381.59M | 1.90M | 396.91M |
Revenue, most recent five fiscal years
| Fiscal year | Natural Alternatives International Inc | Cronos Group Inc. | Mannatech Inc | Marimed Inc. |
|---|---|---|---|---|
| Latest | $129.86M Ended 2025-06-30 | $146.59M Ended 2025-12-31 | $108.04M Ended 2025-12-31 | $159.83M Ended 2025-12-31 |
| 1 year earlier | $113.80M Ended 2024-06-30 | $117.61M Ended 2024-12-31 | $117.87M Ended 2024-12-31 | $157.71M Ended 2024-12-31 |
| 2 years earlier | $154.01M Ended 2023-06-30 | $87.24M Ended 2023-12-31 | $131.96M Ended 2023-12-31 | $148.60M Ended 2023-12-31 |
| 3 years earlier | $170.97M Ended 2022-06-30 | $86.75M Ended 2022-12-31 | $137.21M Ended 2022-12-31 | $134.01M Ended 2022-12-31 |
| 4 years earlier | $178.52M Ended 2021-06-30 | $64.56M Ended 2021-12-31 | $159.76M Ended 2021-12-31 | $121.46M Ended 2021-12-31 |